Approval is only the beginning. Now comes the harder part: identifying the right patients, detecting the disease earlier, and monitoring outcomes so that this promising treatment is effective at scale. The post After Wegovy’s Historic MASH Approval, What’s Next? appeared first on MedCity News.
His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership. The post Secretary Kennedy’s Pride and Prejudice appeared first on MedCity News.
Develop Health’s Series A funding round was led by Wing Venture Capital, and included participation from Afore Capital, J Ventures and South Park Commons. The post Develop Health Secures $14.3M to Streamline Prior Authorization appeared first on MedCity News.
The FDA approved Ionis Pharmaceuticals’ Dawnzera for preventing swelling attacks caused by the rare disease hereditary angioedema. A Takeda Pharmaceutical product dominates this market, but Ionis has clinical data showing patients had better outcomes after switching to Dawnzera from Takeda’s drug and other currently available HAE medications. The post In Crowded Market for a Rare…
At Epic’s annual Users Group Meeting, the EHR behemoth highlighted its growing AI strategy — announcing tools promising to benefit providers, payers and patients alike. The post 3 Announcements You Don’t Want to Miss from Epic’s Annual Meeting appeared first on MedCity News.
A clinically led, cross-functional team approach is essential during medical device integration projects to close data gaps, overcome common project pitfalls, complete optimal testing, and ensure proper oversight. The post The Integration Opportunity: A Blueprint for Reliable Device Data appeared first on MedCity News.
Tools like remote monitoring and smart home integrations have not only increased convenience but also reduced the barriers that often prevent people from seeking or sticking with care, especially among older adults who overwhelmingly prefer to age in place. The post Home Sweet Healthcare: Why the Best Care Setting Is Outside the Clinic appeared first…
[Sponsored] Smarter Technologies CEO Jeremy Delinsky explains how the company’s AI infrastructure can help support health system’s clinical documentation improvement efforts, ultimately strengthening RCM. The post MedCity Pivot Podcast: Clinical Documentation Improvement With Smarter Technologies appeared first on MedCity News.
Array Behavioral Care introduced a new model called Care Pathways, which aims to make mental health treatment more consistent and personalized while also improving patient outcomes. The post Array Behavioral Care Introduces Model for Standardizing Mental Health Treatment appeared first on MedCity News.
Gilead Sciences, whose Kite subsidiary was one of the pioneers of ex vivo cancer cell therapy, is joining the pursuit of in vivo therapies with the acquisition of startup Interius BioTherapeutics. The deal follows AstraZeneca and AbbVie acquisitions this year for in vivo cell therapy developers. The post Gilead Sciences Gains In Vivo Cell Therapy…